세계의 창상 봉합 디바이스 시장 규모는 2023년에 148억 2,000만 달러에 달했습니다. 이 시장은 2024-2030년의 예측 기간 중 7.40%의 CAGR로 확대하며, 2030년에는 226억 4,000만 달러에 달할 것으로 예측됩니다. 창상 봉합 디바이스의 수요는 주로 만성 창상과 급성 창상의 이환율 상승이 지원하고 있습니다. 또한 외과수술의 증가, 주요 시장 참여 기업에 의한 제품의 출시와 승인의 증가가 2024-2030년의 예측 기간 중 창상 봉합 디바이스 시장 전체를 크게 촉진하는 요인이 되고 있습니다.
Diabetes Feet Australia(DFA)가 제공한 최신 데이터(2022년)에 따르면 호주에서는 인구 10만 명당 30만 명이 당뇨병성 족부질환(DFD)에 걸릴 위험이 있으며, 그 중 5만 명이 이미 당뇨병성 족부질환을 앓고 있습니다. 이 중 12,500명이 당뇨병 관련 절단 수술을 받았고, 1,000명이 현재 DFD로 인해 입원 중입니다. 또한 IDF 아틀라스 보고서(2022)가 제공한 최근 데이터와 통계에 따르면 아프리카 국가들의 당뇨병성 족부 궤양(DFU) 비율은 10.0%에서 30.0%, 하지 절단(LLA) 유병률은 3.0%에서 35.0%에 달할 전망입니다. 당뇨병성 족부궤양은 만성적인 상처로 전문적인 치료와 고급 상처 봉합 솔루션이 필요한 경우가 많습니다. 이러한 궤양의 유병률이 증가함에 따라 이러한 상처를 효과적으로 관리하고 봉합할 수 있는 제품에 대한 수요가 증가하고 있습니다. 또한 당뇨병 관련 절단은 초기 상처 관리와 지속적인 치료 모두에 창상 봉합 디바이스가 필요한 경우가 많습니다. 첨단 상처 봉합 제품은 수술 부위의 관리와 치유를 촉진하고 추가 합병증과 재수술의 가능성을 줄이는 데 도움이 됩니다. 이러한 이유로 창상 봉합 디바이스 시장 수요는 예측 기간 중 확대될 것으로 예상됩니다.
또한 기업은 창상 봉합 디바이스의 생산을 확대하고 규제 당국의 승인을 확보함으로써 시장에서의 입지를 전략적으로 확장하고 추가 성장을 가속하고 있습니다. 예를 들어 2023년 6월 Sree Chitra Tirunal Institute for Medical Sciences and Technology(SCTIMST)는 중앙의약품표준관리기구(CDSCO)로부터 Cholederm이라는 첨단 상처 치료 제품에 대한 승인을 받았습니다. Cholederm은 화상 및 당뇨병성 상처를 포함한 다양한 피부 상처의 치유를 촉진하는 데 사용되며, 치료 비용을 절감하고 고급 상처 치료를 보다 저렴하게 만들 것으로 기대되고 있습니다.
그러나 최소침습 수술에 대한 선호도 증가와 감염 위험은 향후 창상 봉합 디바이스 시장의 성장을 저해할 수 있습니다.
세계의 창상 봉합 디바이스 시장에 대해 조사했으며, 시장의 개요와 제품 유형별, 최종사용자별, 지역별 동향 및 시장에 참여하는 기업의 개요 등을 제공하고 있습니다.
Wound Closure Devices by Product Type (Sealants & Adhesives, Staplers, Sutures [Absorbable and Non-Absorbable], Hemostats, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising prevalence of chronic and acute wounds, increase in surgical procedure across the globe, and increase in product launches and approvals by the key market players.
The global wound closure devices market was valued at USD 14.82 billion in 2023, growing at a CAGR of 7.40% during the forecast period from 2024 to 2030, to reach USD 22.64 billion by 2030. The demand for wound closure devices is primarily being boosted by the rising incidence of chronic and acute wounds. Additionally, increasing surgical procedures, and growing product launches and approvals by the key market players are some of the factors responsible for significantly boosting the overall market for wound closure devices during the forecast period from 2024 to 2030.
Wound Closure Devices Market Dynamics:
According to the latest data provided by the Diabetes Feet Australia (DFA) (2022), in Australia, 300,000 individuals are at risk of developing diabetic foot disease (DFD) per 100,000 population, with 50,000 already living with the condition. Of these, 12,500 people have undergone diabetes-related amputations, and 1,000 are currently hospitalized due to DFD. Additionally, as per the recent data and stats provided by IDF Atlas Report (2022), in African countries, the rates of diabetic foot ulcers (DFU) range from 10.0% to 30.0%, while the prevalence of lower limb amputations (LLA) varies between 3.0% and 35.0%. Diabetic foot ulcers are chronic wounds that often require specialized treatment and advanced wound closure solutions. As the prevalence of these ulcers rises, there is a growing demand for products that can effectively manage and close these wounds. Additionally, diabetic-related amputations often require wound closure devices for both the initial wound and ongoing care. Advanced wound closure products help manage surgical sites and promote healing, reducing the likelihood of further complications and repeat surgeries. Thus, the market demand for wound closure device is expected to escalate during the forecasted period.
According to the recent data provided by the World Bank Group, in 2022, Germany performed approximately 19,124 surgical procedures per 100,000 population. Additionally, Finland recorded 15,870 surgical procedures per 100,000 population in the same year. As the number of surgical procedures rises, whether due to a growing population, advancements in medical technology, or more surgeries being performed for various conditions, the need for wound closure devices correspondingly increases thereby escalating the overall market.
Additionally, companies are amplifying their production of wound closure devices and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in June 2023, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) received approval from the Central Drugs Standard Control Organization (CDSCO) for its advanced wound care product called Cholederm. It is used for faster healing of various skin wounds, including burns and diabetic wounds. Cholederm is expected to reduce treatment costs and make advanced wound care more affordable.
Thus, the factors mentioned above are likely to boost the market of wound closure devices during the forecasted period.
However, the rising preference of minimally invasive surgeries and risk of infection may hinder the future market of wound closure devices.
Wound Closure Devices Market Segment Analysis:
Wound Closure Devices by Product Type (Sealants & Adhesives, Staplers, Sutures [Absorbable and Non-Absorbable], Hemostats, and Others), End-User (Hospitals, Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the product type segment of wound closure devices market the sutures are expected to hold a significant share in 2023. Sutures play a significant role in boosting the overall market for wound closure devices due to their widespread use, versatility, and continuous innovation. Sutures are used in a variety of surgical procedures, from minor outpatient surgeries to major operations. Their versatility across different types of wounds and surgeries contributes to their high demand. Sutures are applicable in general surgery, orthopedic surgery, gynecological procedures, and more, broadening their market appeal. Additionally, the development of advanced materials, such as bioabsorbable sutures, antimicrobial-coated sutures, and high-strength synthetic fibers, has enhanced the performance and safety of sutures, driving their adoption. Furthermore, sutures are generally cost-effective compared to some other wound closure options. Their affordability makes them a preferred choice, especially in low-resource settings or where budget constraints are a concern. Moreover, sutures that are compatible with new and minimally invasive surgical techniques, such as laparoscopic surgery, drive their usage in modern medical practices. Sutures used in conjunction with other advanced surgical devices and technologies, such as robotic-assisted surgery, enhance their market presence.
Furthermore, growing recommendation by the government organizations for use of technologically advanced sutures is also a factor that will boost the market growth of sutures. For instance, recently in June 2021, Ethicon Plus sutures became the first-ever suture with antibacterial protection to be recommended for use in NHS by NICE Medical Technologies Guidance as it has been shown to reduce the risk of surgical site infections (SSIs) by nearly 30%.
Hence, all the above-mentioned factors are expected to generate considerable revenue of the segment pushing the overall growth of the global wound closure devices market during the forecast period.
North America is expected to dominate the overall wound closure devices market:
North America is expected to account for the highest proportion of the wound closure devices market in 2023, out of all regions. This can be ascribed to the increasing incidence of chronic and acute wound across the region, growing surgical procedures, and the presence of key market players engaged in merger, acquisition, product launch, and other market activities across the region, which will further escalate the market of wound closure devices during the forecast period.
As per the American Society for Biochemistry and Molecular Biology in the year 2021, in the United States, a brain injury occurs every nine seconds, resulting in more than 3.5 million incidents each year. The above mentioned source further stated that about 2.8 million people suffer from Traumatic Brain Injury (TBI) each year in the United States from which 2,80,000 people result in hospitalizations.
Additionally, as per the recent data provided by the World Bank Group, in 2021, approximately 6,928 surgical procedures were performed per 100,000 population in Canada.
As per the recent data provided by Centre for Disease Control and Prevention (2024), in 2021, 38.4 million people of all ages or 11.6% of the U.S. population had diabetes. Additionally, as per the same source, 80% of Lower-limb amputations (LLAs) are a result of complications from diabetes.
As the global prevalence of diabetes increases, the number of individuals experiencing diabetic wounds and requiring surgical interventions also rises. This leads to higher demand for wound closure devices tailored to managing diabetes-related complications. Furthermore, the rise in surgical procedures, including elective and emergency surgeries, increases the need for wound closure devices. This includes both minor procedures and major surgeries where effective wound closure is crucial thereby escalating the overall market of wound closure devices.
Additionally, the increasing number of product development activities in the region is further going to accelerate the growth of the wound closure devices market. For instance, in October 2023, DuPont announced the introduction of its new DuPont(TM) Liveo(TM) MG 7-9960 Soft Skin Adhesive. The higher-adhesion, low-cyclics silicone soft skin adhesive (SSA) was designed for advanced wound care dressings and for adhering medical devices to the skin for long wear time and gentle removal.
Therefore, the above-mentioned factors are expected to bolster the growth of the wound closure devices market in the North America during the forecast period.
Wound Closure Devices Market Key Players:
Some of the key market players operating in the wound closure devices market include Medtronic, 3M, Johnson & Johnson, B. Braun Melsungen AG, Baxter, Smith & Nephew, Stryker, Chemence Medical, Inc., Healthium Medtech, Meril Life Sciences Pvt. Ltd., Futura Surgicare Pvt Ltd. Advanced Medical Solutions Group plc, Microcure (Suzhou) Medical Technology Co., Ltd., CooperSurgical Inc, Adhezion Biomedical, CENTENIAL SURGICAL SUTURE LTD, Cardinal Health, Dukal LLC, ORION SUTURES INDIA PVT LTD, Lotus Surgicals, and others.
Recent Developmental Activities in the Wound Closure Devices Market:
Key Takeaways From the Wound Closure Devices Market Report Study:
Target Audience who can be Benefited From This Wound Closure Devices Market Report Study:
Frequently Asked Questions for the Wound Closure Devices Market: